COM:VIVORYON
Vivoryon Therapeutics AG
- Stock
locale
Germanymarket
STOCKSindustry
Biotechnologywebsite
www.vivoryon.com/ipo date
Apr 23, 2015
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a small molecule QC inhibitor that has co...Show More